Results 101 to 110 of about 3,423 (190)

Crystal Structure of the Double Homeodomain of DUX4 in Complex with DNA

open access: yesCell Reports, 2018
Double homeobox (DUX) transcription factors are unique to eutherian mammals. DUX4 regulates expression of repetitive elements during early embryogenesis, but misexpression of DUX4 causes facioscapulohumeral muscular dystrophy (FSHD) and translocations overexpressing the DUX4 double homeodomain cause B cell leukemia.
John K. Lee   +9 more
openaire   +3 more sources

DUX4-induced histone variants H3.X and H3.Y mark DUX4 target genes for expression

open access: yes, 2018
Thesis (Ph.D.)--University of Washington, 2018The DUX4 transcription factor is briefly expressed in the cleavage-stage embryo where it induces an early wave of zygotic gene transcription; whereas its mis-expression in skeletal muscle causes the muscular ...
Resnick, Rebecca May
core  

Post-Translational Modifications of the DUX4 Protein Impact Toxic Function in FSHD Cell Models

open access: yes, 2023
Objective: Facioscapulohumeral muscular dystrophy (FSHD) is caused by abnormal de-repression of the myotoxic transcription factor DUX4. Although the transcriptional targets of DUX4 are known, the regulation of DUX4 protein and the molecular consequences ...
Freitas, Michael A   +13 more
core   +1 more source

DUX4-bound regions are similarly activated in FSHD patient myotubes and in DUX4-transduced myoblasts.

open access: yes, 2013
(A) DUX4-bound regions show correlated activation levels in FSHD patient myotubes and in our DUX4-transduced myoblast experimental system. We show log2-activation levels in each system, counting RNA-seq reads within an arbitrary 1 kb of DUX4-bound ...
Zizhen Yao (48910)   +9 more
core   +1 more source

Plenary Abstracts Session & Oral Presentations

open access: yes
HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Interrogating Dux4 Mrna 3′ End Processing

open access: yes, 2016
Double Homeobox 4, Dux4, is the leading candidate gene for Facioscapulohumeral Dystrophy (FSHD). FSHD is the third most common muscular dystrophy, and is characterized by progressive muscle weakness primarily in the upper body.
Peart, Natoya J
core  

Morpholino-mediated Knockdown of DUX4 Toward Facioscapulohumeral Muscular Dystrophy Therapeutics

open access: yes, 2016
Derepression of DUX4 in skeletal muscle has emerged as a likely cause of pathology in facioscapulohumeral muscular dystrophy (FSHD). Here we report on the use of antisense phosphorodiamidate morpholino oligonucleotides to suppress DUX4 expression and ...
Clayton, Nicholas P.   +7 more
core   +1 more source

Poster Sessions

open access: yes
HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

DUX4 is a common driver of immune evasion and immunotherapy failure in metastatic cancers

open access: yeseLife
Cancer immune evasion contributes to checkpoint immunotherapy failure in many patients with metastatic cancers. The embryonic transcription factor DUX4 was recently characterized as a suppressor of interferon-γ signaling and antigen presentation that is ...
Jose Mario Bello Pineda   +1 more
doaj   +1 more source

Epigenetic regulation of DUX4: From embryogenesis to muscular degeneration

open access: yesCurrent Opinion in Cell Biology
DUX4 is a transcription factor with a critical role in zygotic genome activation. It is expressed briefly in early embryogenesis and shut off for the rest of life. Inappropriate reactivation of DUX4 in adult muscle cells causes facioscapulohumeral dystrophy (FSHD), a muscular dystrophy affecting up to 1 in 8000, currently with no cure.
Leyi Li, Arnab Ray, Shifeng Xue
openaire   +2 more sources

Home - About - Disclaimer - Privacy